Tower Research Capital LLC (Trc) Cognition Therapeutics Inc Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 20,970 shares of CGTX stock, worth $10,275. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,970
Previous 10,990
90.81%
Holding current value
$10,275
Previous $5,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CGTX
# of Institutions
50Shares Held
13.4MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$2.94 Million4.39% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$1.08 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$607,3870.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI614KShares$301,1000.01% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$245,0000.0% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $11.1M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...